American Society of Hirudotherapy

Evolution of Reconstructive Microsurgery: 5,113 Free Flaps, One Surgeon, Four Decades

Research article published in Plastic and reconstructive surgery (2026)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportClinical LiteratureLo et al. · Plastic and reconstructive surgery, 2026

Abstract

METHODS: Time-trend analysis of 5,113 consecutive free flaps (1981-2023) from a single surgeon at Chang Gung Memorial Hospital, using segmented regression and joinpoint modelling. RESULTS: 5,113 free flaps included 1,927 ALT, 946 fibula, 1,010 toe transfers, 469 radial, 232 latissimus dorsi and 67 gracilis. INNOVATIONS: ALT introduction was associated with explosive growth (+ 21 flaps/year; p=.003, 1996 to 1999) and rapid substitution of competing soft tissue flaps, with declines in LD, gracilis, and radial forearm. Fibula showed a much slower uptake, with joinpoint models showing moderate growth (+ 2.13 flaps/year; P<.001) until repurposing for mandible reconstruction in 1989. This subsequently correlated with increased site-specific use and tracking of oral cancer incidence (incidence rate ratio = 1.05, p <0.001). LEGISLATION: Toe transfers declined after national Safety Legislation in 1991, with a 4-year lag (-33.7, P<.001). CONCLUSIONS: Microsurgical practice evolves through both technical advances and external forces such as health policy. The contrasting trajectories of the ALT and fibula flaps highlight how innovations reshape reconstructive practice differently. External drivers such as legislation can impact on microsurgical need such as toe transfers. Together these underscore the need for long-range horizons in surgical planning, and the need for intepreting time-trends alongside epidemiological shifts and health policy.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article

Summary

Peer-reviewed clinical and outcomes research relevant to medicinal leech therapy and its biology. Indexed in PubMed and verified against the NCBI record.

Citation

Reference (Vancouver style)

Lo SJ, Wei FC. Evolution of Reconstructive Microsurgery: 5,113 Free Flaps, One Surgeon, Four Decades. Plast Reconstr Surg. 2026. doi:10.1097/PRS.0000000000013191. PMID: 42153674

Bibliographic details (authors, volume, pages, DOI) are taken from the PubMed record.

Added to ASH library: May 28, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.